Outcomes for Patients with Diabetes after Continuous-Flow Left Ventricular Assist Device Implantation

Highlights • Diabetes pre-LVAD implantation was unassociated with mortality during LVAD support. • Diabetes was also not significantly associated with 4 key LVAD adverse event outcomes. • At follow-up, 24% of patients with diabetes pre-LVAD had HbA1c

Saved in:
Bibliographic Details
Published in:Journal of cardiac failure 2016-10, Vol.22 (10), p.789-796
Main Authors: Vest, Amanda R, MBBS MPH, Mistak, Stanley M, BS, Hachamovitch, Rory, MD MSc, Mountis, Maria M, DO, Moazami, Nader, MD, Young, James B, MD
Format: Article
Language:English
Subjects:
Aged
Cardiovascular
Cohort Studies
Comorbidity
diabetes
Diabetes Mellitus - diagnosis
Diabetes Mellitus - epidemiology
Diabetes Mellitus - therapy
Equipment Design
Female
Follow-Up Studies
Heart failure
Heart Failure - diagnostic imaging
Heart Failure - epidemiology
Heart Failure - surgery
Heart-Assist Devices
Hospital Mortality
Humans
left ventricular assist device
Male
Middle Aged
Multivariate Analysis
Proportional Hazards Models
Reference Values
Retrospective Studies
Risk Assessment
Severity of Illness Index
Statistics, Nonparametric
Survival Analysis
transplantation
Treatment Outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Highlights • Diabetes pre-LVAD implantation was unassociated with mortality during LVAD support. • Diabetes was also not significantly associated with 4 key LVAD adverse event outcomes. • At follow-up, 24% of patients with diabetes pre-LVAD had HbA1c
ISSN:1071-9164
1532-8414
DOI:10.1016/j.cardfail.2016.02.010